Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells

European Journal of Cancer

Volumn 48, Issue 16, 2012, Pages 3112-3122

  Laezza, Chiara ^a,b   D'Alessandro, Alba ^c   Paladino, Simona ^b   Malfitano, Anna Maria ^c   Chiara Proto, Maria ^c   Gazzerro, Patrizia ^c   Pisanti, Simona ^c   Santoro, Antonietta ^c   Ciaglia, Elena ^c   Bifulco, Maurizio ^c  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

Author keywords

Anandamide; CB1 receptor; E cadherin; Epithelial mesenchymal transition (EMT); Wnt catenin pathway

Indexed keywords

ANANDAMIDE; BETA CATENIN; DOXORUBICIN; PROTEIN SNAIL1; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOPLASM; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION; WNT SIGNALING PATHWAY;

EID: 84867571354     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.02.062     Document Type: Article

References (42)

1. M. Bifulco, A.M. Malfitano, S. Pisanti, and C. Laezza Endocannabinoids in endocrine and related tumours Endocr Relat Cancer 15 2008 391 408
2. M. Bifulco, C. Laezza, S. Pisanti, and P. Gazzerro Cannabinoids and cancer: pros and cons of an antitumour strategy Br J Pharmacol 148 2006 123 135
3. K. Mackie, and N. Stella Cannabinoid receptors and endocannabinoids: evidence for new players AAPS J 8 2006 E298 E306
4. M. Bifulco, C. Laezza, and G. Portella Control by the endogenous cannabinoid system of rasoncogene-dependent tumor growth FASEB J 15 2001 2745 2747
5. G. Portella, C. Laezza, and G. Laccetti Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading. Actions on signals involved in angiogenesis and metastasis FASEB J 17 2003 1771 1773
6. S. Pisanti, C. Borselli, P. Gazzerro, C. Laezza, and M. Bifulco Antiangiogenetic activity of the endocannabinoidanandamide.Correlation to its tumour-suppressor efficacy J Cell Physiol 211 2007 495 503
7. C. Grimaldi, S. Pisanti, and C. Laezza Anandamide inhibits adhesion and migration of breast cancer cells Exp Cell Res 312 2006 363 373
8. H. Clevers Wnt/beta-catenin signaling in development and disease Cell 127 2006 469 480
9. R. Karim, G. Tse, T. Putti, R. Scolyer, and S. Lee The significance of the Wnt pathway in the pathology of human cancers Pathology 36 2004 120 128
10. A.H. Huber, and W.I. Weis The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin Cell 105 2001 391 402
11. A.M. Brown Wnt signaling in breast cancer: have we come full circle? Breast Cancer Res 3 2001 351 355
12. S.Y. Lin, W. Xia, and J.C. Wang β-Catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression Proc Natl Acad Sci USA 97 2000 4262 4266
13. T.C. He, A.B. Sparks, C. Rago, and Hermeking Identification of c-MYC as a target of the APC pathway Science 281 1998 1509 1512
14. J. Behrens Control of beta-catenin signaling in tumor development Ann NY Acad Sci 910 2000 21 33
15. G. Turashvili, J. Bouchal, G. Burkadze, and Z. Kolar Wnt signaling pathway in mammary gland development and carcinogenesis Pathobiology 73 2006 213 223
16. J.S. Michaelson, and P. Leder β-Catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland Oncogene 20 2001 5093 5099
17. H. Hugo, M.L. Ackland, and T. Blick Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression J Cell Physiol 213 2007 374 383
18. E. Tomaskovic-Crook, E.W. Thompson, and J.P. Thiery Epithelial to mesenchymal transition and breast cancer Breast Cancer Res 11 2009 213
19. B.G. Hollier, K. Evans, and S.A. Mani The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies J Mammary Gland Biol Neoplasia 14 2009 29 43
20. C. Laezza, S. Pisanti, E. Crescenzi, and M. Bifulco Anandamide inhibits Cdk2 and activates Chk1leading to cell cycle arrest in human breast cancer cells FEBS Lett 580 2006 5082 6076
21. L. De Petrocellis, D. Melck, and A. Palmisano The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation Proc Natl Acad Sci USA 95 1998 8375 8380
22. C. Liu, Y. Li, and M. Semenov Control of beta-catenin phosphorylation/degradation by a dual kinase mechanism Cell 108 2002 837 847
23. K. Tamai, X. Zeng, C. Liu, X. Zhang, and Y. Harada A mechanism for Wnt co-receptor activation Mol Cell 13 2004 149 156
24. X. Zeng, K. Tamai, and B. Doble A dual-kinase mechanism for Wntco-receptor phosphorylation and activation Nature 438 2005 873 877
25. K. Mi, P.J. Dolan, and G.V. Johnson The low density lipoprotein receptor related protein 6 interacts with glycogen synthase kinase 3 and attenuates activity J Biol Chem 281 2006 4787 4794
26. L. Larue, and A. Bellacosa Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways Oncogene 24 2005 7443 7454
27. T. Blick, E. Widodo, and H. Hugo Epithelial mesenchymal transition traits in human breast cancer cell lines Clin Exp Metastasis 25 2008 629 642
28. J.I. Yook, X.Y. Li, and I. Ota A Wnt-Axin2-3β cascade regulates Snail1 activity in breast cancer cells Nat Cell Biol 8 2006 1398 1406
29. M. Conacci-Sorrell, I. Simcha, and T. Ben-Yedidia Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of β-catenin signaling, slug, and MAPK J Cell Biol 163 2003 847 857
30. L.R. Howe, O. Watanabe, J. Leonard, and A.M. Brown Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation Cancer Res 63 2003 1906 1913
31. Q.Q. Li, J.D. Xu, and W.J. Wang Twist1-mediated Adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells Clin Cancer Res 15 2009 2657 2665
32. J.M. Lee, S. Dedhar, R. Kalluri, and E.W. Thompson The epithelial-mesenchymal transition: new insights in signaling, development, and disease J Cell Biol 172 2006 973 981
33. M. Jo, R.D. Lester, and V. Montel Reversibility of epithelial-mesenchymal transition (EMT) induced in breast cancer cells by activation of urokinase receptor-dependent cell signaling J Biol Chem 284 2009 22825-2283
34. B.R. Henderson, and F. Fagotto The ins and outs of APC and beta-catenin nuclear transport EMBO Rep 9 2002 834 839
35. G.V. Rayasam, V.K. Tulasi, R. Sodhi, J.A. Davis, and A. Ray A glycogen synthase kinase 3: more than a namesake Br J Pharmacol 156 2009 885 898
36. S. Dihlmann, and D.M. von Knebel Wnt/β-catenin-pathway as a molecular target for future anti-cancer therapeutics Int J Cancer 113 2005 515 524
37. J.I. Yook, X.Y. Li, and I. Ota A Wnt-Axin2-3β cascade regulates Snail1 activity in breast cancer cells Nat Cell Biol 8 2006 1398 1406
38. M. Conacci-Sorrell, I. Simcha, and T. Ben-Yedidia Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of β-catenin signaling, slug, and MAPK J Cell Biol 163 2003 847 857
39. L.R. Howe, O. Watanabe, J. Leonard, and A.M. Brown Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation Cancer Res 63 2003 1906 1913
40. R.B. Hazan, R. Qiao, R. Keren, I. Badano, and K. Suyama Cadherin switch in tumor progression Ann NY Acad Sci 1014 2004 155 183
41. E. Batlle, E. Sancho, and C. Franci The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells Nat Cell Biol 2 2000 84 89
42. J. Ivaska, H.M. Pallari, J. Nevo, and J.E. Eriksson Novel functions of vimentin in cell adhesion, migration, and signaling Exp Cell Res 313 2007 2050 2062